Analysis of aspartate aminotransferase-to-platelet ratio index and liver fibrosis in biliary atresia
Journal of the Colleges of Medicine of South Africa · 17.08.2026 · 4 (1)
DOI: 10.4102/jcmsa.v4i1.447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Colleges of Medicine of South Africa, online erschienen am 17.08.2026. Verfasst von Elizabeth Brits und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aspartate aminotransferase-to-platelet ratio index (APRi) has been proposed as a non-invasive biomarker of liver injury in biliary atresia (BA). However, conflicting evidence and varying cutoff values have left its association with histologically confirmed liver damage uncertain. This study assessed the relationship between APRi and liver injury severity (Meta-Analysis of Histological Data in Viral Hepatitis [METAVIR] F0–F4) in BA and evaluated its predictive value.
Methods
A retrospective analytical review of electronic records was conducted for all BA patients treated at a South African academic hospital between 01 January 2009 and 31 December 2019.
Results
Sixty-seven patients were included, 74.6% of whom were female. The most common subtypes were cytomegalovirus (CMV) immunoglobulin M-positive (IgM+) BA (34.3%) and isolated BA (31.3%); about one-third could not be classified because CMV serology was unavailable. Liver biopsy METAVIR scores were F1 (8.3%), F2 (50.0%), F3 (18.3%) and F4 (23.3%). In a sub-analysis (n = 39), APRi modestly differentiated ≤ F2 from ≥ F3 fibrosis at a cutoff of 2.69 (area under the receiver operating characteristic curve 0.61). Decision curve analysis suggested modest clinical utility despite a non-significant logistic regression model (odds ratio 1.25; 95% confidence interval 0.94–1.92; p = 0.2). Of the 55 patients with known outcomes, 94.5% (n = 52) had confirmed mortality or were referred for palliative care.
Conclusion
Aminotransferase-to-platelet ratio index should not replace established clinical decision-making but may provide useful adjunctive information alongside clinical, biochemical and histological assessment. These findings provide contextual evidence from a South African resource-limited setting and support prospective multicentre validation before routine clinical implementation. Contribution: The study contributes evidence supporting continued evaluation of APRi as an adjunctive non-invasive biomarker in BA in the South African setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
- Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
- Department of Health Sciences, Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein, South Africa.
ORCID-Profile: Elizabeth Brits, Stephen Brown, Lezelle Botes, Michael Pienaar
Zitieren
APA
Brits, E., Brown, S., Botes, L., & Pienaar, M. (2026). Analysis of aspartate aminotransferase-to-platelet ratio index and liver fibrosis in biliary atresia. Journal of the Colleges of Medicine of South Africa, 4(1). https://doi.org/10.4102/jcmsa.v4i1.447
Vancouver
Brits E, Brown S, Botes L, Pienaar M. Analysis of aspartate aminotransferase-to-platelet ratio index and liver fibrosis in biliary atresia. Journal of the Colleges of Medicine of South Africa. 2026;4(1). doi:10.4102/jcmsa.v4i1.447
BibTeX
@article{Brits2026,
author = {Brits, Elizabeth and Brown, Stephen and Botes, Lezelle and Pienaar, Michael},
title = {Analysis of aspartate aminotransferase-to-platelet ratio index and liver fibrosis in biliary atresia},
journal = {Journal of the Colleges of Medicine of South Africa},
year = {2026},
volume = {4},
number = {1},
doi = {10.4102/jcmsa.v4i1.447}
}
EUVIMED